Structures by: Guillaumet G.
Total: 16
C7H9BrN4O3
C7H9BrN4O3
Organic letters (2003) 5, 24 4595-4598
a=21.859(2)Å b=21.859(2)Å c=4.2150(10)Å
α=90.00° β=90.00° γ=90.00°
C10H9BrN4
C10H9BrN4
Organic letters (2009) 11, 23 5502-5505
a=8.6380(10)Å b=6.3800(10)Å c=18.833(3)Å
α=90.00° β=94.20(2)° γ=90.00°
C16H19BrN4O
C16H19BrN4O
Organic letters (2009) 11, 23 5502-5505
a=7.5380(10)Å b=10.542(2)Å c=12.0440(10)Å
α=98.908(10)° β=102.359(10)° γ=109.915(10)°
C10H7BrN4O2
C10H7BrN4O2
Organic letters (2009) 11, 23 5502-5505
a=10.595(2)Å b=7.426(3)Å c=13.938(2)Å
α=90.00° β=90.00° γ=90.00°
C48.5H59ClN11
C48.5H59ClN11
New Journal of Chemistry (2018) 42, 8 5728
a=11.8594(6)Å b=13.3077(7)Å c=15.7675(8)Å
α=105.058(4)° β=101.304(4)° γ=96.287(4)°
C50H62N11
C50H62N11
New Journal of Chemistry (2018) 42, 8 5728
a=24.6041(16)Å b=6.0490(7)Å c=31.305(3)Å
α=90° β=92.106(6)° γ=90°
1-(4-(5-(trifluoromethyl)imidazo[1,2-a]pyrimidin-7-yl)phenyl)ethan-1-one
C15H10F3N3O
New Journal of Chemistry (2019) 43, 25 9961
a=13.2871(6)Å b=7.3989(4)Å c=14.1570(10)Å
α=90° β=104.735(7)° γ=90°
C18H17N5O
C18H17N5O
RSC Advances (2019) 9, 50 29051
a=10.7895(4)Å b=14.8634(7)Å c=10.0794(5)Å
α=90° β=92.246(4)° γ=90°
C15H11N5O2
C15H11N5O2
RSC Adv. (2015) 5, 44 35201
a=6.8520(10)Å b=9.607(5)Å c=10.857(7)Å
α=102.68(4)° β=93.21(3)° γ=92.50(3)°
C23H14F3N4O
C23H14F3N4O
RSC Adv. (2015) 5, 44 35201
a=43.065(3)Å b=5.4072(11)Å c=17.347(8)Å
α=90° β=91.73(2)° γ=90°
2(S)-7-methoxy-2-(3-(R)-4,5-dihydro-4,4-dimethyl-3H-2-oxo-3-oxicarbonyl)- 2,3-dihydro-1,4-benzodioxin
C16H18O7
Acta Crystallographica Section C (1999) 55, 3 387-389
a=10.313(4)Å b=11.871(2)Å c=12.713(2)Å
α=90.00° β=90.00° γ=90.00°
7-Chloro-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidine
C13H10ClN3
Acta Crystallographica Section E (2013) 69, 5 o749
a=6.5993(2)Å b=12.6166(4)Å c=13.8702(5)Å
α=90.00° β=100.131(2)° γ=90.00°
<i>N</i>-(2-Bromo-4-methylphenyl)-2-(5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-7-yl)acetamide
C22H19BrN4O
Acta Crystallographica Section E (2013) 69, 6 o829
a=9.8102(6)Å b=7.2915(4)Å c=27.0162(14)Å
α=90.00° β=92.942(3)° γ=90.00°
Ethyl 7-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidine-5-carboxylate
C16H15N3O2
Acta Crystallographica Section E (2013) 69, 5 o740
a=8.0542(8)Å b=16.4104(19)Å c=21.635(2)Å
α=90.00° β=90.00° γ=90.00°
C28H27N3O
C28H27N3O
The Journal of organic chemistry (2015) 80, 17 8539-8551
a=11.5931(2)Å b=10.9324(2)Å c=18.2371(13)Å
α=90° β=92.902(7)° γ=90°
(<i>Z</i>)-1,3-diallyl-4-(2-oxopropylidene)-4,5-dihydro-1<i>H</i>-1,5- benzodiazepin-2(3<i>H</i>)-one
C18H20N2O2
Zeitschrift für Kristallographie - New Crystal Structures (2008) 223, 4 435
a=8.889(4)Å b=9.062(2)Å c=11.0870(10)Å
α=111.270(10)° β=94.91(2)° γ=104.80(3)°